Cyber Resilience

CVE-2023-6078

HighRCE

Published: 01 February 2024

Published
01 February 2024
Modified
21 November 2024
KEV Added
—
Patch
—
CVSS Score v3.1 8.8 CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
EPSS Score 0.0034 57.3th percentile
Risk Priority 18 60% EPSS · 20% KEV · 20% CVSS

Summary

CVE-2023-6078 is a high-severity OS Command Injection (CWE-78) vulnerability in 3Ds Biovia Materials Studio. Its CVSS base score is 8.8 (High).

Operationally, ranked in the top 42.7% of CVEs by exploit likelihood; it is not currently listed in the CISA KEV catalog.

EU & UK References

Vulnerability details

An OS Command Injection vulnerability exists in BIOVIA Materials Studio products from Release BIOVIA 2021 through Release BIOVIA 2023. Upload of a specially crafted perl script can lead to arbitrary command execution.

CWE(s)
CWE-78

Related Threats

No named actor attribution yet. ATT&CK technique mapping in progress for this CVE.

Affected Assets

3ds
biovia materials studio
2021 — 2023

Mitigating Controls

Likely Mitigating Controls AI

Per-CVE control mapping for this CVE has not run yet; the list below is derived from the weakness types (CWEs) cited in the NVD entry.

SC-27 Platform-independent Applications
addresses: CWE-78

Platform-independent apps typically execute inside a managed runtime or sandbox that restricts direct OS command execution, reducing the ability to exploit OS command injection.

SI-10 Information Input Validation
addresses: CWE-78

Validates inputs to block special elements that would alter OS command execution.

References